## **Trustees' Annual Report for the period** Period start date Period end date Day Month Year Day Month Year 01 04 2024 **To** 31 03 2025 **From** ## Section A Reference and administration details **Charity name Other names charity is known by Registered charity number (if any)** 1180082 The Head and Neck Cancer Research Trust **Charity's principal address** c/o 4[th] Floor, Eldon Chambers 30-32 Fleet Street London **Postcode EC4Y 1AA** ## **Names of the charity trustees who manage the charity** |1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20|**Trustee name**|**Office (if any)**|**Dates acted if not for whole**
**year **|**Name of person (or body) entitled**
**to appoint trustee (ifany)**| |---|---|---|---|---| ||Karen Wint|Chair||| ||Dr Amie Mertens|Trustee||| ||Dr Vessela
Vassileva|Trustee|01/04/2024 – 04/12/2024|| |||||| |||||| |||||| |||||| |||||| |||||| |||||| |||||| |||||| |||||| |||||| |||||| |||||| |||||| |||||| |||||| |||||| **Names of the trustees for the charity, if any, (for example, any custodian trustees)** **Name Dates acted if not for whole year** March **2012** **TAR** 1 ## **Names and addresses of advisers (Optional information)** |**Names and addresses of advisers (Optional information)**|**Names and addresses of advisers (Optional information)**|**Names and addresses of advisers (Optional information)**| |---|---|---| |**Type of adviser**
**Name**
**Address**||| |**Accountant**|Kershen Fairfax Ltd|4thFloor, Eldon Chambers, 30-32 Fleet Street, London,
EC4Y 1AA| |||| |||| |||| ## **Name of chief executive or names of senior staff members (Optional information)** ## **Section B Structure, governance and management** ## **Description of the charity’s trusts** Constitution Type of governing document (eg. trust deed, constitution) CIO How the charity is constituted - (eg. trust, association, company) Appointed Trustee selection methods (eg. appointed by, elected by) ## **Additional governance issues (Optional information)** You **may choose** to include additional information, where relevant, about: - policies and procedures adopted for the induction and training of trustees; - the charity’s organisational structure and any wider network with which the charity works; - relationship with any related parties; - trustees’ consideration of major risks and the system and procedures to manage them. ## **Section C Objectives and activities** **Summary of the objects of the charity set out in its governing document** **FOR THE PUBLIC BENEFIT THE RELIEF OF SICKNESS AND THE PROMOTION AND PROTECTION OF GOOD HEALTH BY THE ADVANCEMENT OF RESEARCH INTO PREVENTION, EARLY DETECTION AND TREATMENT OF HUMAN PAPILLOMAVIRUS (HPV)-ASSOCIATED HEAD AND NECK CANCER AND OTHER HEAD AND NECK CANCERS BY THE PROVISION OF RESEARCH GRANTS AND TO DISSEMINATE THE USEFUL RESULTS OF SUCH RESEARCH.** March **2012** **TAR** 2 **Host of the annual EUSICA/INSICA international meeting in May 2025, in collaboration with Oncology Professional Care. A two day interdisciplinary clinical and research meeting bringing together the top researchers and clinicians/ surgeons from across the world in the field of rare head and neck tumours, sinonasal cancers and brain tumours. Running alongside this was a skull base surgery skill course for surgical trainees.** **Research Grants awarded to Professor M. Lechner, Honorary Research Fellows and a PhD student from the Division of Surgery and Interventional Science, UCL cancer institute. In particular for Summary of the main their work in translational research on sinonasal cancers and HPV activities undertaken for the associated oropharyngeal cancer, with the aim of improving public benefit in relation to prevention, early detection and treatment. these objects (include within this section the statutory Development and expansion of the HNCR Trust Instagram account. declaration that trustees have Led voluntarily by a Medical Doctor. had regard to the guidance issued by the Charity Continued membership of the NCVO. Commission on public benefit) The Trustees have supported events and activities in regard to the** **The Trustees have supported events and activities in regard to the guidance issued by the Charity Commission on public benefit (PB1).** ## **Additional details of objectives and activities (Optional information)** You **may choose** to include further statements, where relevant, about: - policy on grantmaking; - policy programme related investment; - contribution made by volunteers. March **2012** **TAR** 3 Section D Achievements and performance **Summary of the main achievements of the charity during the year** **The charity has had its largest income during the tax year 24/25, since its establishment in 2018. This is due to hosting the EUSICA/INSICA-Brain conference in collaboration with Oncology Professional Care. Conference sponsorship and ticket sales provided the main charity income for this tax year. This money was used primarily in organising the conference and was a one-off opportunity for the charity. The unique opportunity as Trustees, to be involved with such a large international event provided valuable experience in event management for the future.** **The usual income of the charity comes from Donations from individuals and other charities. This money was partly used to fund research projects in the field of head and neck cancers. The cash funds remaining in the account are used for payments such as the website, accountant and insurance.** **This year the Trustees were able to donate the most funds the charity has ever had the capacity to do. The cash funds at the end of the year are also the highest remaining and the Trustees look forward to being able to support further research projects and public awareness programmes in the following tax year.** March **2012** **TAR** 4 ## **Section E Financial review** **Brief statement of the** **charity’s policy on reserves** **The charity has no specific policy on reserves as income each year is neither regular nor known in advance. As such funds will only be spent if there are sufficient cash reserves.** **Details of any funds materially in deficit** ## **Further financial review details (Optional information)** You **may choose** to include additional information, where relevant about: - the charity’s principal sources of funds (including any fundraising); - how expenditure has supported the key objectives of the charity; - investment policy and objectives including any ethical investment policy adopted. ## **Section F Other optional information** ## **Section G Declaration** **The trustees declare that they have approved the trustees’ report above.** **Signed on behalf of the charity’s trustees** ## **Signature(s)** **----- Start of picture text -----**
|| |---| |A Mertens| **----- End of picture text -----**
**Full name(s)** Dr A Mertens **Position (eg Secretary, Chair,** Trustee **etc) Date** 22/09/2025 March **2012** **TAR** 5 **The Head and Neck Cancer Research Trust No (if any) 1180082 Receipts and payments accounts CC16a For the period** Period start date Period end date **To from** 01/04/2024 31/03/2025 ## **Section A Receipts and payments** |**A1 Receipts**|**Unrestricted**
**funds**
**to the nearest £**
**4,438**
**17,000**
**13,921**
**-**
**-**
**-**
**-**
**-**

**35,359**
**-**
**-**
**-**
**35,359**|**Unrestricted**
**funds**
**to the nearest £**
**4,438**
**17,000**
**13,921**
**-**
**-**
**-**
**-**
**-**

**35,359**
**-**
**-**
**-**
**35,359**|**Restricted**
**funds**
**to the nearest £**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**|**Restricted**
**funds**
**to the nearest £**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**|**Endowment**
**funds**
**to the nearest £**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**|**Endowment**
**funds**
**to the nearest £**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**|**Total funds**
**to the nearest £**
**4,438**
**17,000**
**13,921**
**-**
**-**
**-**
**-**
**-**
**35,359**
**-**
**-**
**-**
**35,359**
**696**
**17,804**
**24,955**
**3,328**
**60**
**50**
**420**
**1,407**
**48,720**
**-**
**-**
**-**
**48,720**

**- 13,361**|**Total funds**
**to the nearest £**
**4,438**
**17,000**
**13,921**
**-**
**-**
**-**
**-**
**-**
**35,359**
**-**
**-**
**-**
**35,359**
**696**
**17,804**
**24,955**
**3,328**
**60**
**50**
**420**
**1,407**
**48,720**
**-**
**-**
**-**
**48,720**

**- 13,361**|**Last year**
**to the nearest £**| |---|---|---|---|---|---|---|---|---|---| |Donations|**4,438**||||||||**23,032**| |Conference sponsorship|**17,000**||||||||**-**| |Conference ticket sales|**13,921**||||||||**-**| ||**-**||||||||**-**| ||**-**||||||||**-**| ||**-**||||||||**-**| ||**-**||||||||**-**| ||**-**||||||||**-**| |**_Sub total_**_(Gross income for_
_AR)_|
**35,359**||||||||**23,032**| ||||||||||| |**A2 Asset and investment sales,**
**(see table).**|||||||||| ||**-**||||||||| ||**-**||||||||**-**| |**_Sub total_**|**-**||||||||**-**| |**_Total receipts_ **
**A3 Payments**|||||||||| ||||||||||**23,032**| ||||||||||| |Computer costs|**696**||**-**||**-**||**696**||**1,025**| |Conference expenses|**17,804**||**-**||**-**||**17,804**||**508**| |Post conference expenses|**24,955**||**-**||**-**||**24,955**||| |Researchgrants|**3,328**||**-**||**-**||**3,328**||**4,000**| |Sponsorshipcosts|**60**||**-**||**-**||**60**||**786**| |Advertisingcosts|**50**||**-**||**-**||**50**||**200**| |Accountancyfees|**420**||**-**||**-**||**420**||**300**| |Other expenses|**1,407**||**-**||**-**||**1,407**||**107**| |**_Sub total_ **|**48,720**||**-**||**-**||**48,720**||**6,926**| ||||||||||| |**A4 Asset and investment**
**purchases, (see table)**|||||||||| ||**-**||||||||| ||**-**||||||||| |**_Sub total_ **|**-**||||||||**-**| |**_Total payments_**
**_Net of receipts/(payments)_**
**A5 Transfers between funds**
**A6 Cash funds last year end**
**_Cash funds this year end_**|||||||||| ||||||||||**6,926**| ||||||||||| ||**- 13,361**||||||
**- 13,361**||**16,106**| ||**-**||||||**-**||**-**| ||**17,365**||||||**17,365**||**1,259**| ||**4,004**||||||**4,004**||**17,365**| CCXX R1 accounts (SS) 22/09/2025 1 ## **Section B Statement of assets and liabilities at the end of the period** |**Categories**
Signed by one or two trustees on
behalf of all the trustees
**B5 Liabilities**
**B3 Investment assets**
**B2 Other monetary assets**
**B4 Assets retained for the**
**charity’s own use**
**B1 Cash funds**|**Details**
**Details**
**_Total cash funds_**
(agree balances with receipts and payments
account(s))
NatWest bank account
**Details**
**Details**
**Details**
Signature
_A Mertens_|**Unrestricted**
**funds**
**Restricted**
**funds**
**to nearest £**
**to nearest £**
**4,004**
**-**
**-**
**-**
**-**
**-**
**4,004**
**-**
OK
OK
**Unrestricted**
**funds**
**Restricted**
**funds**
**to nearest £**
**to nearest £**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**Fund to which**
**asset belongs**
**Cost (optional)**
**-**
**-**
**-**
**-**
**-**
**Fund to which**
**asset belongs**
**Cost (optional)**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**Fund to which**
**liability relates**
**Amount due**
**(optional)**
**-**
**-**
**-**
**-**
**-**
Print Name
A Mertens|**Endowment**
**funds**
**to nearest £**| |---|---|---|---| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||OK| ||||**Endowment**
**funds**
**to nearest £**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**Current value**
**(optional)**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**Current value**
**(optional)**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**When due**
**(optional)**| ||||| ||||| ||||| ||||| ||||| ||||| ||||Date of
approval| ||_A Mertens_|A Mertens|22.09.25| ||||| CCXX R2 accounts (SS) 22/09/2025 2 ## **Independent examiner's report on the accounts** **Section A Independent Examiner’s Report** **Report to the trustees/** Charity Name The Head and Neck Cancer Research Trust **members of On accounts for the year** 31[st] March 2025 **Charity no** 1180082 **ended (if any) Set out on pages** 1-2 (remember to include the page numbers of additional sheets) I report to the trustees on my examination of the accounts of the above charity (“the Trust”) for the year ended 31/03/2025. - **Responsibilities and** As the charity trustees of the Trust, you are responsible for the preparation **basis of report** of the accounts in accordance with the requirements of the Charities Act 2011 (“the Act”). I report in respect of my examination of the Trust’s accounts carried out under section 145 of the 2011 Act and in carrying out my examination, I have followed the applicable Directions given by the Charity Commission under section 145(5)(b) of the Act. **Independent** I have completed my examination. I confirm that no material matters have **examiner's statement** come to my attention (other than that disclosed below *) in connection with the examination which gives me cause to believe that in, any material respect: - accounting records were not kept in accordance with section 130 of the Act or - the accounts do not accord with the accounting records I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in order to enable a proper understanding of the accounts to be reached. * _Please delete the words in the brackets if they do not apply._ **Date:** 22/09/2025 **Signed: Name:** M D Cox **Relevant professional** ACA FCCA **qualification(s) or body (if any): Address:** c/o Kershen Fairfax Ltd, 4[th] Floor, Eldon Chambers 30-32 Fleet Street, London EC4Y 1AA 1 **October 2018** **IER** **Section B Disclosure** Only complete if the examiner needs to highlight matters of concern (see CC32, Independent examination of charity accounts: directions and guidance for examiners). **Give here brief details of any items that the examiner wishes to disclose** . 2 **October 2018** **IER**